GOLDMAN SACHS GROUP INC - BURNING ROCK BIOTECH LTD ownership

BURNING ROCK BIOTECH LTD's ticker is BNR and the CUSIP is 12233L107. A total of 54 filers reported holding BURNING ROCK BIOTECH LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of BURNING ROCK BIOTECH LTD
ValueSharesWeighting
Q4 2022$124,767
-67.8%
55,452
+36.4%
0.00%
Q4 2021$387,000
-73.5%
40,660
-50.2%
0.00%
Q3 2021$1,461,000
-34.0%
81,686
+8.7%
0.00%
Q2 2021$2,215,000
-88.0%
75,179
-89.0%
0.00%
-100.0%
Q1 2021$18,444,000
+2067.3%
685,136
+1918.7%
0.01%
Q3 2020$851,000
+5.1%
33,939
+13.1%
0.00%
Q2 2020$810,00030,0000.00%
Other shareholders
BURNING ROCK BIOTECH LTD shareholders Q1 2021
NameSharesValueWeighting ↓
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,812,569$48,957,0003.80%
Casdin Capital, LLC 1,730,786$46,749,0002.77%
Orbimed Advisors 4,746,071$128,191,0001.80%
HSG Holding Ltd 212,121$5,729,0001.02%
Aspex Management (HK) Ltd 292,418$7,898,0000.97%
Pinz Capital Management, LP 30,000$810,0000.37%
Cormorant Asset Management, LP 250,000$6,753,0000.26%
Hudson Bay Capital Management LP 537,311$14,512,0000.25%
Rock Springs Capital Management LP 200,000$5,402,0000.15%
Monashee Investment Management LLC 30,000$810,0000.12%
View complete list of BURNING ROCK BIOTECH LTD shareholders